prostate-specific antigen (PSA) test, a blood test used to detect prostatic cancer and to monitor the patient’s response to therapy. The PSA velocity monitors the change in PSA with time, and the percent-free PSA is assessed as an independent predictor of prostate cancer risk. Currently, PSA is considered the most sensitive tumor marker for this type of cancer.